Syneron Medical Ltd (ELOS) Reports In-Line Q1 EPS

Syneron Medical Ltd (NASDAQ: ELOS) reported Q1 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $56.8 million versus the consensus estimate of $55.5 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• Parker Hannifin completes acquisition of Filtration Group Corporation
• Morgan Stanley comments on Japanese chemical firms posting strong quarterly results